Leading market players are investing heavily in the research and development in order to expand their product lines, which will help the Aesthetic Implants Devices market grow even more. Market players are also undertaking different strategic activities to spread their global footprint, with important market developments inclusive of contractual agreements, mergers and acquisitions, new product launches, higher investments, and collaboration with the other organizations. To expand and survive in the more competitive and rising market climate, the Aesthetic Implants Devices industry must offer the cost-effective items.
Manufacturing locally to minimize the operational costs is one of the key business tactics used by the manufacturers in the global Aesthetic Implants Devices industry to benefit the clients and grow the market sector. In recent years, the Aesthetic implant devices industry has provided some of the most significant advantages to the cosmetic industry.
Major players in the Aesthetic Implants Devices market, including Mentor Worldwide LLC, Sientra, Inc., Allergen (AbbVie Inc.), GC Aesthetics, POLYTECH Health & Aesthetic GmbH, Institut Straumann AG, Dentsply Sirona, Implantech, 3M, and others, are trying to surge market demand by investing in the research and development operations.
Merz Aesthetics, the global leader in the field of aesthetics, is a subsidiary of the Merz Group. Merz has established itself as a prime player in the healthcare and aesthetics industry. Renowned for its commitment to advancing the field, the company offers solutions that address different aesthetic concerns, including facial wrinkles, volume loss, and skin aging. Merz Aesthetics emphasizes developing and marketing a broad range of innovative and minimally invasive products for aesthetic medicine. In July 2023, Merz Aesthetics, a global leader in medical aesthetics, acquired Silhouette, a French company known for its innovative thread lift procedures.
This move expands Merz's portfolio into non-surgical facial rejuvenation and strengthens its presence in Europe.
Ellansé is a popular brand in the field of aesthetic medicine, providing a unique range of dermal fillers known for their innovative composition and long-lasting results. Ellansé products are known for their advanced technology in the realm of non-surgical facial rejuvenation. Its use of a proprietary bioresorbable and biostimulatory polymer called polycaprolactone (PCL) in its fillers offers not only an immediate volumizing effect but also stimulates the body's collagen production for sustained, natural-looking results.
In May 2023, Ellansé, a manufacturer of long-lasting dermal fillers, partnered with Sinclair Pharma, a UK-based aesthetics company specializing in biostimulatory injectables. This collaboration combines their expertise to develop new hyaluronic acid-based products for facial rejuvenation.